ANNUAL REPORT FOR FY 2025-26

N G INDUSTRIES LTD CIN: L74140 WB 1994 PLC 065937, GSTIN: 19AABCN6332QIZX Phone: 033 2419 7542, +91 80175 20040, +91 83358 20040 email: ngmail@ngil.co.in website: www.ngind.com 1st Floor, 37A Southern Avenue, Kolkata – 700 029 (Renamed as Dr. Meghnad Saha Sarani) August 31, 2026 To To The Secretary The Secretary Bombay Stock Exchange Limited The Calcutta Stock Exchange Ltd. Registered Office: Floor 25, 7, Lyons Range P.J. Towers, Dalal Street, Kolkata – 700 001 Mumbai – 400 001 Scrip Code No. 530897 Scrip Code No. 10024075 Dear Sir/madam, Report and Accounts for the financial year ended 31st March, 2026 We enclose, in terms of Regulation 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a copy of the Report and Accounts of the Company for the financial year ended 31st March, 2026 together with the Notice dated 28th May, 2026 convening the 32nd Annual General Meeting (AGM) of the Company on 26th September, 2026. The aforesaid Report and Accounts and AGM Notice are also being uploaded on the Company’s website www.ngind.com. Kindly take the above in your record. Thanking You, Yours Faithfully, For N G Industries Ltd Bratati Bhattacharya Company Secretary & Compliance Officer ANNUAL REPORT DUSTRIES LIMITED I/ ' HWT Q COMPANY CHARTEREDeACCOUNTANTS N G INDUSTRIES LTD ANNUAL REPORT 2025-2026 CIN:L74140WB1994PLC065937 BOARD OF DIRECTORS : Mr. Rajesh Goenka, Chairman & Whole-time Director Mr. Pramod Kumar Dhelia Mr. Satya Prakash Tolasaria Mrs. Neha Goenka CHIEF FINANCIAL OFFICER : Mr. Santosh Kumar Thakur COMPANY SECRETARY : Mrs. Bratati Bhattacharya AUDITORS : M. R. SlNGHWl & Co. BANKERS : Indian Bank HDFC Bank Ltd. Standard Chartered Bank State Bank of lndia Bank of lndia Yes Bank REGISTERED OFFICE : 1s t Floor 37A, Dr Meghnad Saha Sarani, Kolkata - 700 029 Phone: 033 2419 7542,801 75 20040 E-mail: ngmail@ngil.co.in Website: www.ngind.com DIVISIONS : 1. N G Medicare & Calcutta Hope Infertility Clinic 123A, Rash Behari Avenue, Kolkata - 700 029 : 2. N G Nursing Home 23, Dr Meghnad Saha Sarani, Kolkata 700 026 : 3. N G Pharmacy 12 3A, Rash Behari Avenue, Kolkata 700 029 23, Dr Meghnad Saha Sarani, Kolkata 700 026 REGISTRARS & SHARE TRANSFER AGENTS : S.K. Infosolutions Private Limited Dl42, Katju Nagar Colony, Jadavpur, Kolkata - 700032 LISTING OF SHARES : 1. The Calcutta Stock Exchange Limited 2. Bombay Stock Exchange Limited N G INDUSJ.RIES LTD DIRECTORS' REPORT TO THE MEMBERS: Your Directors have pleasure in presenting the 32nd Annual Report on the affairs of the Company together with the Audited Financial Statements for the financial year ended on 31st March, 2026. FINANCIAL RESULTS: The financial results of the Company for the year ended 31'' March, 2026 is summarized below: Rupees in Thousands Particulars 2025-26 2024-25 Revenue from Operations 16,39,48.31 16.54,68.56 Other Income 1.02.95.13 8.00.06.23 Profit Before Financial Cost, depreciation, exceptional items and 2,81,26.94 1 9,79,81.50 Less: Financial Costs 7,2566 4,37.71 Profit before Depreciation, exceptional items and Tax 294.01.28 9,75,43.79 Less: A) Depreciation 59.38.07 61,26.24 0) Provision for Taxation - Current Tax 39.75.00 1.38,35.00 - Deferred Tax 1,27.36 1,64.53 -Adjustment of tax relating for earlier years 23.20 23.47 Net Profitl (Loss) after Tax 1.73.37.65 7,73,94.55 Total comprehensive income for the year (3.78,35.27) 3,5553.73 Balance carried forward to Balance Sheet (3.78,35.27) 3,55.53.73 OPERATIONS AND PROSPECTS: N G Industries Ltd. operates an integrated healthcare facility comprising Doctor Clinics, Outpatient Services, a Diagnostic Laboratory, an Indoor Facility with wards and ICU, Surgical Infrastructure, Dialysis Services, Special Clinics including Infertility, Retail Pharmacies, Home Care Services and an Adult Vaccination Unit. Dialysis Services were commenced during the year under review, extending the Company's indoor and specialised-care capabilities to patients requiring chronic and critical renal care. The healthcare sector in India continues to be shaped by rapid technology adoption, wider insurance coverage, digitisation of patient records and changing patient expectations. Locally, Kolkata's healthcare landscape has seen ownership changes among some of the larger hospital groups, altering the competitive dynamics the Company operates within. During the year under review, the global economic environment was significantly influenced by the conflict between Iran and the United States, which escalated tensions in the Middle East, a region central to global energy supply. This uncertainty pushed up international crude oil prices, and the resultant pressure on India's import bill contributed to a depreciation of the Indian Rupee against major currencies. The combined effect of higher crude prices and a weaker Rupee fed through into a broader inflationary environment across the economy. Costs of transportation, fuel, and several categories of imported and import-linked goods rose in tandem, and this in turn placed N G INDUSTRIES LTD pressure on overall input costs for businesses across sectors. For the common citizen, this translated into a general increase in the cost of living, which, alongside stagnant wage growth in several segments, had the effect of reducing purchasing power, particularly for households at the lower and middle end of the income spectrum. Reduced purchasing power among the masses typically has a dampening effect on discretionary spending, and healthcare - while largely a necessity-driven sector - is not entirely insulated from such pressures. The Company remains mindful of this environment while balancing the need to maintain quality of service against the imperative of keeping healthcare accessible and affordable. Separately, West Bengal saw a change in its State Government following the Assembly elections during the year. Any resulting shifts in State health policy, insurance schemes, or regulatory approach are not yet clear at this stage, and the Company will engage with the new administration in the same constructive manner as it hatwith previous ones, adapting its operations as the policy direction becomes evident. Sector trends we expect to shape the coming years include wider adoption of digital and Al- based diagnostic tools, continued expansion of cashless insurance networks, and a shift toward value-based and home-based care. The Company is positioning its systems and service mix to respond to these shifts as they take hold. Operating performance for the year was muted, weighed down by input cost inflation and a competitive market, though the Company remained debt-free and continued its practice of consistent dividend payouts, interrupted only during the pandemic years. This financial discipline continues to underpin our ability to absorb external shocks without resort to borrowing. Our approach to ethics and quality of care remains unchanged, and we record our appreciation of the clinical, administrative and support teams who deliver it. Going into FY 2026-27, priorities include strengthening our outpatient and diagnostic base, expanding preventive, digital-health and geriatric-care offerings, and deepening engagement with referring doctors and other stakeholders. We consider the Company's performance for 2025-26 satisfactory given the operating environment described above, and expect a gradual return to stronger growth as conditions stabilise. We thank our shareholders, patients, employees and partners for their continued confidence in the Company. There was no chahge in the nature of the business of the Company during the year, and there was no change in the composition of the Board of Directors. DIVIDEND AND TRANSFER TO RESERVE: The Board is pleased to recommend a dividend of 7 3.50 per Equity Share of 7 10 each (i.e. 35%) for the year ended March 31, 2026. The said dividend on equity shares is subject to the approval of the shareholders at the ensuing Annual General Meeting N G INDUSTRIES LT [Showing first 8,000 characters — download PDF for full document]